vimarsana.com

Latest Breaking News On - Voyager therapeutics inc - Page 8 : vimarsana.com

Voyager Therapeutics: Q4 Earnings Snapshot -February 28, 2024 at 04:34 pm EST

LEXINGTON, Mass. LEXINGTON, Mass. Voyager Therapeutics Inc. on Wednesday reported fourth-quarter net income of $56.4 million. The Lexington, Massachusetts-based company said it had.

Massachusetts
United-states
Zacks-investment-research
Voyager-therapeutics-inc
Investment-research
Automated-insights
Markets

Why Okta Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket - Okta (NASDAQ:OKTA)

Shares of Okta, Inc. (NASDAQ: OKTA) shares rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and

Oprah-winfrey
Sridhar-ramaswamy
Frank-slootman
Ww-international-inc
Milestone-pharmaceuticals-inc
Indaptus-therapeutics-inc
Snowflake-inc
Holdings-limited
Envoy-medical-inc
Shoals-technologies-group-inc
Corerx-inc
Voyager-therapeutics-inc

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the four analysts that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1 year […]

Voyager-therapeutics-inc
Td-asset-management-inc
Kestra-advisory-services
Nasdaq
Wells-fargo-company
Voyager-therapeutics
Get-free-report
Advisory-services
Wealth-management
Management-inc
Aigen-investment-management

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Free Report) has been given an average recommendation of “Moderate Buy” by the four brokerages that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month […]

Canada
Nasdaq
Voyager-therapeutics-inc
Vanguard-group-inc
Royal-bank
Capital-management
Wells-fargo-company
Barclays-plc
Voyager-therapeutics-company-profile
Bridgeway-capital-management
Voyager-therapeutics

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.